App-Enhanced Brief Cognitive-Behavioral Therapy for Suicidal and Self-injurious Behaviour

Phase-Based Progress Estimates
Anxiety Disorders Center, Institute of Living, Hartford, CT
Suicidal and Self-injurious Behaviour+1 More
App-Enhanced Brief Cognitive-Behavioral Therapy - Behavioral
18 - 65
All Sexes
What conditions do you have?

Study Summary

The purpose of this study is to evaluate the feasibility of integrating Brief Cognitive-Behavioral Therapy (BCBT) counseling with a software application (app) to prevent future suicidal thoughts and behaviors.

Eligible Conditions

  • Suicidal and Self-injurious Behaviour

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

8 Primary · 0 Secondary · Reporting Duration: 3 months post-discharge from inpatient unit

1 month after discharge
Suicidal Ideation 1 month
2 months after discharge
Suicidal Ideation 2 months
3 months after discharge
Suicidal Ideation 3 months
Month 3
Frequency of suicide attempts
Day 16
App Usability at Discharge
Client Satisfaction at Discharge
Suicidal Ideation at Discharge
Baseline (before receiving BCBT intervention)
Suicidal Ideation Baseline

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

App-Enhanced Brief Cognitive-Behavioral Therapy
1 of 1
Experimental Treatment

4 Total Participants · 1 Treatment Group

Primary Treatment: App-Enhanced Brief Cognitive-Behavioral Therapy · No Placebo Group · N/A

App-Enhanced Brief Cognitive-Behavioral Therapy
Experimental Group · 1 Intervention: App-Enhanced Brief Cognitive-Behavioral Therapy · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 months post-discharge from inpatient unit
Closest Location: Anxiety Disorders Center, Institute of Living · Hartford, CT
Photo of connecticut 1Photo of connecticut 2Photo of connecticut 3
2019First Recorded Clinical Trial
1 TrialsResearching Suicidal and Self-injurious Behaviour
1 CompletedClinical Trials

Who is running the clinical trial?

Oui Therapeutics, LLCIndustry Sponsor
3 Previous Clinical Trials
426 Total Patients Enrolled
Hartford HospitalLead Sponsor
116 Previous Clinical Trials
16,933 Total Patients Enrolled
David Tolin, PhDPrincipal InvestigatorAnxiety Disorders Center, Institute of Living
3 Previous Clinical Trials
139 Total Patients Enrolled
Gretchen Diefenbach, PhDPrincipal InvestigatorAnxiety Disorders Center, Institute of Living

Eligibility Criteria

Age 18 - 65 · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a history of suicide attempt and active ideation on admission.
You have access to your phone and can download apps during your inpatient stay.
You are able to understand the nature of the study and provide written informed consent.
You are willing and able to provide at least two verifiable contacts for emergency or tracking purposes.
You are expected to complete the entire treatment protocol.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.